Dr. Badani discusses PSMA-targeting agents in prostate cancer

“There's going to be a whole slew of interesting therapies that are about to emerge for prostate cancer, adds Ketan K. Badani, MD, in this video. Badani is a professor of urology at Icahn School of Medicine at Mount Sinai, vice chairman of urology and robotic operations at Mount Sinai Health System, director of robotic surgery at Mount Sinai West, and the director of the Comprehensive Kidney Cancer Program At Mount Sinai Health System, New York.

Related Videos
Benjamin Lowentritt, MD, FACS, in an interview with Urology Times
Dr. Goldfischer in an interview during the LUGPA Annual Meeting
Related Content
© 2023 MJH Life Sciences

All rights reserved.